Trial Profile
COX-2 alteration in advanced colon cancer treated with capecitabine versus 5-fluorouracil and calcium folinate (Mayo regimen) combination.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil; Folinic acid
- Indications Colon cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2011 New trial record